EP 1714153 A2 20061025 - A POLYPEPTIDE DERIVED FROM GP41, A VACCINE COMPOSITION COMPRISING SAID POLYPEPTIDE, AND USES FOR TREATING AN INFECTION BY AN HIV VIRUS IN AN INDIVIDUAL
Title (en)
A POLYPEPTIDE DERIVED FROM GP41, A VACCINE COMPOSITION COMPRISING SAID POLYPEPTIDE, AND USES FOR TREATING AN INFECTION BY AN HIV VIRUS IN AN INDIVIDUAL
Title (de)
VON GP41 ABGELEITETES POLYPEPTID, DAS POLYPEPTID ENTHALTENDE IMPFSTOFFZUSAMMENSETZUNG SOWIE VERWENDUNGEN ZUR BEHANDLUNG EINER HIV-VIRUSINFEKTION IN EINEM INDIVIDUUM
Title (fr)
POLYPEPTIDE DERIVE DE GP41, COMPOSITION DE VACCIN COMPRENANT CE POLYPEPTIDE ET UTILISATIONS DE CELLE-CI POUR TRAITER UNE PERSONNE INFECTEE PAR UN VIRUS VIH
Publication
Application
Priority
- EP 2005001395 W 20050207
- EP 2004001106 W 20040206
- EP 05715302 A 20050207
IPC 8 full level
G01N 33/569 (2006.01); A61K 38/03 (2006.01)
Citation (search report)
See references of WO 2005076001A2
Citation (examination)
- WO 8707616 A1 19871217 - BIOGEN NV [NL], et al
- WO 8808429 A1 19881103 - BIOGEN NV [NL], et al
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR
DOCDB simple family (publication)
DOCDB simple family (application)
EP 05715302 A 20050207